GGrantIndex
Sort

166,118 grants matching stem cells

Transcriptional condensates, epigenetic editing and Rett Syndrome

$903,497
Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2021 · MH

Myocardial Repair by Targeted Stem Cells

$903,306
James W Larrick · Panorama Research, Inc. · R44 · FY2008 · HL

REACTIVE OXYGEN SPECIES: STRESS AND DAMAGE IN OLD MUSCLE

$903,261
University Of Michigan At Ann Arbor · P01 · FY2002 · AG

Integrated Cellular and Tissue Engineering for Ischemic Heart Disease

$903,257
Jianyi Zhang · University Of Alabama At Birmingham · U01 · FY2017 · HL

Hormonal and Paracrine Regulation of Spermatogenesis

$903,248
Barry R Zirkin · Johns Hopkins University · U54 · FY2007 · HD

Role of clonal somatic mutations in microglia and Alzheimer’s disease

$903,172
Yue Huang · Boston Children'S Hospital · R01 · FY2024 · AG

Hormonal and Paracrine Regulation of Spermatogenesis

$903,079
Barry R Zirkin · Johns Hopkins University · U54 · FY2008 · HD

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$903,048
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DA

Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids

$903,048
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA

Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum

$903,045
Jeffrey H Stern · Stemcultures, Llc · R42 · FY2023 · GM

National Gene Vector Biorepository and Coordinating Center at Indiana University

$903,034
Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2012 · HL

Core B: Clinical Core

$902,942
Douglas R Galasko · University Of California, San Diego · P30 · FY2025 · AG

Therapeutic Targeting of Malignant Glioma Stem Cells

$902,878
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2018 · CA

ADIPOSE STEM CELL-BASED THERAPEUTIC TARGETING OF RESIDUAL ANDROGENS IN AFRICAN AMERICANS WITH BONE-METASTATIC PROSTATE CANCER

$902,853
The Administrators Of Tulane Educational Fund · · FY2011 · Department of Defense

Development of Natural Product Leads as Anticancer Therapeutics

$902,657
John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease

$902,529
Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG

Development of Human Intestinal Simulacra

$902,507
Nancy L Allbritton · Univ Of North Carolina Chapel Hill · R01 · FY2015 · DK

Endoderm Induction and Pancreatic Specification from ES*

$902,506
Gordon M Keller · University Health Network · U01 · FY2006 · DK

Cancer Etiology, Prevention, Detection and Diagnosis

$902,334
Amato J. Giaccia · Stanford University · T32 · FY2007 · CA

Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia

$902,320
James J Hickman · Hesperos, Llc · R44 · FY2021 · AG

Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia

$902,299
James J Hickman · Hesperos, Llc · R44 · FY2022 · AG

Human Energy and Body Weight Regulation Core

$902,209
Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2021 · DK

Dynamic Complexity of Brain Tumor Stem Cells

$902,102
Jeremy N Rich · University Of California, San Diego · R35 · FY2019 · CA

Targeting breast cancer stem cells

$902,098
Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2019 · CA

Epstein-Barr Virus Associated Disorders

$902,035
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI